McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM (2015) Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jdar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbll T
Potential Side Effects, Contraindications, and Safety Questions GLP-1 medications have a well-documented safety profile, and it's worth knowing it before you start - not after your first injection
#BPC157 #LeakyGut #RegenerativeMedicine #GutHealth #IntestinoPermeable #MedicinaRegenerativa #SaludIntestinal | ISSCA
The clinical gap is bigger than the GI gap.